Vitamin D and rheumatic diseases. – Review July 2014

Reumatismo. 2014 Jul 28;66(2):153-70. doi: 10.4081/reumatismo.2014.788.
Rossini M1, Gatti D, Viapiana O, Caimmi C, Idolazzi L, Fracassi E, Adami S.
1Rheumatology Unit, University of Verona. maurizio.rossini@univr.it.

Vitamin D has some well-known effects on calcium, phosphate and bone metabolism, but it has recently shown to have many other effects, which may potentially be relevant to patients with extra-skeletal rheumatic diseases.
Such effects may be justified by:

  • 1) the presence of the vitamin D receptors also on extra-osseous cells, such as cartilage cells, sinoviocytes, muscle cells;
  • 2) the proven role of vitamin D in the control of the transcription of genes involved in rheumatic diseases;
  • 3) the evidence that vitamin D has multiple endocrine effects not only on calcium homeostasis;
  • 4) the activation of vitamin D not only in the kidneys,
    but also in monocyte-macrophage and lymphocytic cell lines
    and in some epithelial cells with additional intracrine and paracrine effects.

Vitamin D deficiency has been reported in numerous metabolic, degenerative, inflammatory and autoimmune rheumatic diseases. In some cases this association was also related to the risk of developing a rheumatic disease or the degree of disease activity.
However there is no conclusive evidence of the efficacy of a preventive or therapeutic strategy based on vitamin D supplementation in extra-skeletal rheumatic diseases. This review aims to provide an overview of the latest evidence concerning the relationship between vitamin D and the most relevant rheumatic diseases.

PMID: 25069497

PDF is attached at the bottom of this page



Image Image Image Image Image


See also VitaminDWiki

7750 visitors, last modified 30 Jul, 2014,
Printer Friendly Follow this page for updates